Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Reducing the Risk of Late-Stage Failure with In Silico Modeling

Posted on June 15th, 2016 by in Pharma R&D

In silico modeling is arguably one of the hottest trends in life sciences R&D today. We know that bringing drug discovery to the desktop impacts cost. Continue reading “Reducing the Risk of Late-Stage Failure with In Silico Modeling” »

Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?

Posted on January 12th, 2016 by in Pharma R&D

It’s the turn of the year and if you’re like me, you’ve been immersed in reading all of the accompanying look back and look ahead articles and reports. 2015 was, indeed, a notable year — from the Martin Shkreli fiasco to the proposed Pfizer and Allergan merger — the industry was rocked. Continue reading “Does improving pre-clinical research reduce late-stage failures and improve R&D productivity?” »